Please ensure Javascript is enabled for purposes of website accessibility
Early Opportunies
Get in Before the Crowd

October 18, 2022

With a new Issue of Cabot Early Opportunities dropping tomorrow, tax loss harvesting season in full swing and a market swinging between being up and down significantly day to day (not to mention intra-day), we’re slashing a few positions today.

Portfolio Adjustments

With a new Issue of Cabot Early Opportunities dropping tomorrow, tax loss harvesting season in full swing and a market swinging between being up and down significantly day to day (not to mention intra-day), we’re slashing a few positions today.

First up is Caribou Sciences (CRBU). We haven’t had the stock that long and data out this morning on the first patient dosed in the Phase 1 ANTLER trial sounds good. But the stock is down over both the last month and the last three weeks and has diverged from the broader biotech group (up over the last three weeks). That alone may not be reason to sell the stock, but as we look to keep our portfolio to a reasonable size and try to balance risk vs. reward, CRBU’s recent weakness has pushed it to the top of the sell list. We only ever added a half-sized position, and we’ll sell it today. SELL

Fisker (FSR) has been with us for a while and it hasn’t delivered, though production is slated to ramp up very soon. With a sizeable paper loss of over 50%, this is a screaming tax loss harvesting candidate. Especially since we can slide in another name offering similar exposure that may just have better near-term potential (hint, hint, more on this in tomorrow’s Issue). SELL

Tyler Laundon is chief analyst of the limited-subscription advisory, Cabot Small-Cap Confidential and grand slam advisory Cabot Early Opportunities. He has spent his entire career managing, consulting and analyzing start-up and small-cap companies. His hands-on experience has taught Tyler that the development of a superior business model is the biggest factor in determining a company’s long-term success. Accordingly, his research focuses on assessing the viability of management’s growth strategies, trends in addressable markets and achievement of major developmental milestones.